VEGF-C is associated with lymphatic status and invasion in oral cancer by Siriwardena, B S M S et al.
VEGF-C is associated with lymphatic status and
invasion in oral cancer;
B S M S Siriwardena,1,3 Y Kudo,1 I Ogawa,2 M N G P K Udagama,3 W M Tilakaratne,3
T Takata1
1 Department of Oral and
Maxillofacial Pathobiology,
Division of Frontier Medical
Science, Graduate School of
Biomedical Sciences, Hiroshima
University, Hiroshima, Japan;




3 Department of Oral Pathology,
Faculty of Dental Sciences,
University of Peradeniya, Sri
Lanka
Correspondence to:
Dr Yasusei Kudo, Department of
Oral and Maxillofacial
Pathobiology, Division of Frontier
Medical Science, Graduate









Background: Nodal metastasis is a major prognostic
indicator for oral squamous cell carcinoma (OSCC)
progression. Recently, it has been revealed that
lymphangiogenic growth factor VEGF-C and its receptor
Flt-4 play an important role for invasion and metastasis in
cancer cells.
Aim: To examine VEGF-C expression and its correlation
with lymphatic status, including the number of lymph
vessels and lymphatic invasion, tumour invasion and
metastasis in OSCC.
Methods: Intratumoural and peritumoural lymphatic
vessels were examined using D2-40 in 54 OSCC cases
and correlated with VEGF-C expression and clinicopatho-
logical findings. The histological pattern of invasion and
pathological findings were compared.
Results: High expression of VEGF-C was frequently
observed in OSCC and was associated with increased
number of lymph vessels and lymphatic invasion. VEGF-C
was well correlated with invasion pattern and metastasis.
Conclusions: Results suggest that VEGF-C may play an
important role for lymphangiogenesis and invasion in the
metastatic process and can be a strong predicting factor
for metastasis of OSCC.
Millions of people die every year from the
metastatic spread of cancer that occurs via the
blood vessels, lymph vessels or directly into tissues
and body cavities.1 It was previously thought that
lymphatic metastasis involved passage of malig-
nant cells along pre-existing lymph vessels near a
tumour. However, recent studies using animal
models suggest that lymphangiogenesis can be
induced by solid tumours and may promote
tumour spread.2 Moreover, it has been revealed
that lymphangiogenesis can occur adjacent to or
within cancers and correlates with lymph node
metastasis.3 4 It was difficult in the past to analyse
lymphatics, due to the lack of lymphatic-specific
markers that could be used to discriminate
between lymphatics and blood vessels. The
recently developed monoclonal antibody D2-40
detects a fixation-resistant epitope on podopla-
nin.5 6 It has been shown to be a selective marker
for lymphatic endothelium, allowing the specific
identification of lymphatic vessels in formalin
fixed, paraffin-embedded tissue and the study of
lymph vessel density in solid tumours.6–9
VEGF-C is involved in lymphangiogenesis via
effects of activated Flt-4 on lymphatic endothelial
cells.10 11 Examination of VEGF-C function in a
number of assays has also shown an angiogenic
activity, presumably via activation of VEGFR-2.12
Su et al suggest that the Flt-4 ligand, VEGF-C, may
affect cancer development or progression by direct
effect on tumour cells.13 In order to determine the
roles of VEGF-C for lymphangiogenesis in OSCC,
we examined VEGF-C expression and its correla-
tion with lymphatic status.
MATERIALS AND METHODS
All OSCC samples were used after approval by the
ethical committees of our institutions and
informed consent by the patients.
Patients and tumour samples
Archived paraffin-embedded tissue specimens from
54 previously untreated patients with OSCC were
obtained from the Department of Oral Pathology,
Faculty of Dental Sciences, University of
Peradeniya, Sri Lanka. A further 18 OSCC speci-
mens were obtained from the same hospital and
were immediately frozen and stored at 280uC. All
had surgery as their first line of management.
Twenty-four patients had histologically confirmed
metastatic spread to the neck nodes.
Reverse-transcriptase PCR
Total RNA was isolated from tumour tissues using
the RNeasy Mini Kit (Qiagen, Hilden, Germany).
Preparations were quantified and their purity was
determined by standard spectrophotometric meth-
ods. cDNA was synthesised from 1 mg total RNA
according to the ReverTra Dash (Toyobo
Biochemicals, Tokyo, Japan). Two pairs of primer
sequences were: VEGF-C, 59-GGA AAG AAG TTC
CAC CAC CA-39 (forward) and 59-TTT GTT AGC
ATG GAC CCA CA-39 (reverse); human GAPDH,
59-TCC ACC ACC CTG TTG CTG TA-39 (for-
ward) and 59-ACC ACA GTC CAT GCC ATC AC-
39 (reverse). Aliquots of total cDNA were amplified
with 1.25 U of rTaq-DNA polymerase (Qiagen);
amplifications were performed in a PC701 thermal
cycler (Astec, Fukuoka, Japan) for 30 cycles after an
initial 20 second denaturation at 94uC, annealed
for 30 s at 60uC, and extended for 1 min at 72uC in
all primers.
Immunohistochemical analyses
Formalin fixed, paraffin embedded tumour tissues
were cut into 4 mm thick sections and stained with
H&E for histological examination. Invasive margin
of the tumour was graded as types I, II, III and IV
according to the Bryne’s invasive front grading.14
For immunohistochemical examination, the
EnVision system was used. The tissue sections
were deparaffinised and rehydrated in a graded
series of alcohols. Endogenous peroxidase activity
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was blocked with 0.3% H2O2 for 30 min. The sections were
microwaved three times for 5 min each in citrate phosphate
buffer (pH 6.0) for antigen retrieval. The sections were then
incubated with protein block serum free medium for 10 min to
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Figure 1 High expression of VEGF-C and lymphatic status in oral squamous cell carcinoma (OSCC). (A) Expression of VEGF-C mRNA by RT-PCR.
GAPDH expression was used as a control. (B) Representative cases of high and low VEGF-C expression in OSCC. Bar= 50 mm. VEGF-C expression is
observed in cytoplasm of OSCC cells. (C) Immunoreactivity for D2-40. Vascular endothelial cells show no immunoreactivity (arrows). Bar= 25 mm. (D)
Left: intratumoural (IT) lymph vessels show immunoreactivity for D2-40 (bar= 100 mm). Right: lymph vessels located at the invasive edge of tumours
(PT, peritumoural area) are observed (bar= 100 mm). (E) A comparison between number of lymph vessels in IT and PT area and nodal metastasis in 54
OSCC. Average number of IT lymph vessels in OSCC cases without nodal metastasis is 5.7 (SD 4.8) and that in OSCC cases with nodal metastasis is
9.7 (SD 7.6). Average number of lymph vessels in PT area showed highly significant results with lymph node metastasis. Average number of lymph
vessels in OSCC cases without nodal metastasis is 6.6 (SD 3.5) and that in OSCC cases with nodal metastasis is 11.8 (SD 7.0). *p,0.05.
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block non-specific binding. Monoclonal antibody of D2-40
(Signet, Dedham, Massachusetts, USA; dilution 1:40) and
VEGF-C (polyclonal antibody, Santa Cruz Biotechnology Inc.,
Santa Cruz, California, USA; dilution 1:25) were applied as
primary antibodies and incubated at 4uC overnight. After
washing with phosphate buffered saline, secondary antibodies
were applied to the sections, which were then incubated for one
hour at room temperature. Primary antibody was visualised
with diaminobenzidine. Sections were counterstained with
Mayer’s haematoxylin, dehydrated and mounted. VEGF-C
expression was graded as high (.10% of tumour cells showed
strong or diffuse immunopositivity) or low (,10% of tumour
cells showed weak or focal immunopositivity or no staining).
Evaluation of intratumoural and peritumoural lymphangiogenesis
Two distinct sets of measurements were performed in each
tumour section; five fields with the highest lymphatic vascular
density were identified in all 54 cases, (i) within the tumour and
(ii) within an area of 1 mm from the tumour border (along the
invasive front). In each, selected fields were microphotographed
and the positively stained lymph vessels traced using Adobe
Photoshop software. Average values of vessel counts in the total
of 10 high power fields (6100) were obtained from each tumour.
Whole tumour area was scanned to determine tumour invasion
into lymph vessels. The results were then compared with other
parameters. The three pathologists (SS, YK and IO) made all the
assessments.
In vitro invasion assay
MSCC-1 and MSCC-Inv1 cells were previously established in
our laboratory. Using these cells, in vitro invasion assay was
performed as described previously.15
Statistical analysis
Possible correlation between variables of the analysed tumour
samples and association between lymphatic invasion and lymph
node metastasis, invasion pattern, and VEGF-C expression were
tested by the x2 test. For the correlation between number of
lymph vessels and lymph node metastasis, lymphatic invasion
and pattern of invasion, statistical significance was measured by
the Welch test. For VEGF-C expression, statistical significance
with IT and PT was also measured by the Welch test. A p value
,0.05 was required for significance.
RESULTS
VEGF-C expression and lymphatic status in OSCC
It has been reported that promotion of tumour metastasis by
VEGF-C is due to the induction of lymphangiogenesis via effects
of activated Flt-4 on lymphatic endothelial cells.10 11 To
determine the role of VEGF-C for lymphangiogenesis in
OSCC, we examined VEGF-C expression and lymph vessels
status. VEGF-C mRNA was expressed in 15 of 18 (83%) OSCC
tissues by reverse transcriptase (RT)-PCR (fig 1A). By immu-
nohistochemical analysis, high expression of VEGF-C was
observed in 37 of 54 (68.5%) OSCC cases (fig 1B). Next, we
examined the lymphatic status by immunohistochemistry using
the D2-40 antibody in OSCC. The D2-40 antibody specifically
recognised lymphatic endothelial cells; in contrast, blood vessels
showed no immunostaining (fig 1C). The D2-40 lymph vessels
were unevenly distributed throughout the tumours. We
counted the number of lymph vessels in the IT area (within
the tumour area) and PT area (within an area of 1 mm from the
invasive front). The number of lymph vessels located in the PT
area was higher than that in IT area (fig 1D). Moreover, OSCC
cases with nodal metastasis showed a significantly higher
number of lymph vessels in both the IT (p=0.028) and PT
(p=0.002) areas than those without nodal metastasis (fig 1E). <
It is widely accepted that the invasion of tumour cells into
lymph vessels is one of the critical steps for the establishment of
metastasis. As expected, D2-40 immunostaining also high-
lighted the presence of lymphatic invasion (fig 2A).
Interestingly, lymphatic invasion was mostly present in the
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Figure 2 Lymphatic invasion in oral
squamous cell carcinoma. (A)
Representative case of lymphatic invasion
by tumour cells. Lymph vessels are
stained by D2-40. Arrow shows tumour
cells, which invaded into the lumen of a
lymph vessel. Bar= 25 mm. (B) Invasion
of tumour cells into lymph vessels was
significantly correlated with intratumoural
(IT) lymph vessels (p= 0.008) compared
to peritumoural (PT) lymph vessels
(p= 0.171). (C) Correlation between
lymphatic invasion and nodal metastasis.
Tumours with higher lymphatic invasion
showed higher metastatic rate.
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PT area. Of 54 OSCC cases, 27 (50%) showed lymphatic
invasion. Lymphatic invasion was significantly correlated with
IT lymphatics (p=0.008) compared to PT lymphatics
(p=0.171) (fig 2B). Of 27 cases with lymphatic invasion, 19
(70.4%) had nodal metastasis. On the other hand, only 5/27
(18.5%) cases without lymphatic invasion had nodal metastasis.
Thus, correlation between lymphatic invasion and nodal
metastasis was highly significant (p,0.001) (fig 2C).
Correlation between VEGF-C expression and lymphatic status
We compared the expression of VEGF-C with lymphatic status,
including the number of lymph vessels and lymphatic invasion
by tumour cells. Interestingly, the number of lymph vessels in
both IT and PT areas was significantly associated with VEGF-C
expression (IT, p=0.033; PT, p=0.021) (fig 3A and table 1).
Furthermore, 62% of cases with high expression of VEGF-C
showed lymphatic invasion, whereas only 23.5% of cases with
low expression of VEGF-C showed lymphatic invasion, indicat-
ing that the tumours with lymphatic invasion showed
significantly higher expression of VEGF-C (p=0.008) (fig 3B
and table 1).
Relationship of VEGF-C expression with invasion and metastasis
VEGF-C and ligand Flt-4 play an important role in invasion and
metastasis in malignant tumour cells.10 11 We previously isolated
a highly invasive clone (MSCC-Inv1) from parent OSCC cells
(MSCC-1) by using an in vitro invasion assay method.15 16
Interestingly, MSCC-Inv1 with higher expression of VEGF-C
mRNA showed higher invasive activity, in comparison with
MSCC-1 with lower expression of VEGF-C mRNA (fig 4A).
Moreover, VEGF-C expression was correlated with pattern of
invasion (p,0.001) in OSCC, where 95% of pattern IV cases
expressed VEGF-C in contrast with pattern I cases which
showed no VEGF-C expression (fig 4B and table 1). These
results indicate that VEGF-C may play an important role in
invasion of OSCC. Furthermore, VEGF-C expression was
correlated with metastasis (p=0.007) (fig 4C and table 1).
DISCUSSION
OSCC is one of the most common cancers; the overall 5-year
survival rate is low, largely because of the propensity of some
tumours to disseminate via the lymphatics. Indeed, the finding
of lymph node involvement is one of the strongest indicators of
poor prognosis. Hence, there is an urgent need to identify
characteristics of the primary tumours that might predict nodal
metastasis. Here, we examined lymphatic status, including the
number of lymph vessels and lymphatic invasion and correlated
them with metastasis in OSCC. We found that IT and PT
lymphatics were associated with increased tendency for nodal
metastasis. In support of this, the retrospective analyses of head
and neck and breast cancer samples have shown a positive
correlation between tumoural lymphatics and lymphatic
metastasis.3 17 The main significance of tumour invasion to
lymph vessels is that they could provide a possible route for the
spread of tumour cells to regional lymph nodes. Interestingly,
we found a significant correlation between lymphatic invasion
and metastasis. Lymphatic invasion was mostly found in the PT
area, not in IT lymphatics. This finding is consistent with a
previous report that metastases were discovered despite no
detectable IT lymphatics.18 Padera et al proposed that IT
lymphatics might not be completely functional because of
collapse of IT vessels under high intratumoural pressure.18 We
found that both IT and PT lymphatics were associated with
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Figure 3 A possible correlation between VEGF-C expression and
lymphatic status. (A) Correlation between VEGF-C expression and
number of intratumoural (IT) and peritumoural (PT) lymph vessels.
*p,0.05. (B) Correlation between VEGF-C expression and lymphatic
invasion.
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nodal metastasis. It has been reported that PT lymphatics are
associated with lymphatic metastasis in head and neck, prostate
and cervical carcinoma.3 19 20 However, other studies showed
that IT lymphatics are vital for lymphatic metastasis.3 21 As
lymphatic invasion was mostly found in PT lymphatics, we
speculate that local lymph vessels at the tumour margin (PT
area) are more important for spreading tumour cells. However,
to clarify whether IT and/or PT vessels contribute to lymphatic
metastasis, further studies will be required.
VEGF-C was found to have a specific function in lymphan-
giogenesis. Several groups have reported a possible correlation
between VEGF-C expression and metastasis in OSCC.
However, there has been no report on the correlation between
VEGF-C expression and lymphatic status. Here, we showed that
high expression of VEGF-C mRNA and protein was frequently
observed in OSCC, and VEGF-C expression was correlated with
increased number of lymph vessels and lymphatic invasion. In
addition to lymphangiogenesis, it has recently been shown that
the VEGF-C/Flt-4 axis enhances cancer cell mobility and
invasiveness and contributes to the promotion of metastasis.13
Here we observed that VEGF-C expression was significantly
correlated with invasion pattern and nodal metastasis.
Interestingly, a highly invasive clone isolated by in vitro
invasion assay showed a higher expression of VEGF-C, in
comparison with the parent OSCC cell line. We suggest that
VEGF-C plays an important role for tumour invasion as well as
lymphangiogenesis. VEGF-C produced by cancer cells may
enhance lymphangiogenesis and tumour invasion, leading to
nodal metastasis.
In summary, our findings suggest that VEGF-C expression
may be involved in lymphangiogenesis and invasion of OSCC
cells in the metastatic process, and that determination of VEGF-
C expression can be a strong predicting factor for metastasis of
OSCC. We conclude that there might be an option for future
therapeutic intervention by obstructing lymphatic invasion or
lymphangiogenesis.
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Lymph node metastasis
2 30 14 16 0.007{
+ 24 3 21
*VEGF-C expression was graded as high (.10% of tumour cells showed strong or diffuse immunopositivity) and low (,10% of
tumour cells showed weak or focal immunopositivity or no staining).
{x2 test, {Welch test.
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Figure 4 VEGF-C expression is correlated with invasion and
metastasis. (A) Left panel shows invasive activity of parent cells (MSCC-
1) and a highly invasive clone (MSCC-Inv1). Invasion was determined by
in vitro invasion assay. Right panel shows VEGF-C mRNA expression in
parent cells and a highly invasive clone. VEGF-C mRNA expression was
examined by RT-PCR. GAPDH expression was used as a control. (B)
Correlation between VEGF-C expression and pattern of invasion. (C)
Correlation between VEGF-C expression and nodal metastasis.
Take-home message
Promotion of tumour metastasis by VEGF-C is thought to be due
to the induction of tumour lymphangiogenesis.
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